Scleritis as the presenting manifestation of procainamide-induced lupus

P. W. Turgeon, Thomas L. Slamovits

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Scleritis developed in a patient using procainamide as part of drug-induced lupus syndrome. Systemic findings, which developed after the onset of ocular signs and symptoms, included arthralgias, myalgias, weight loss, and markedly elevated antinuclear antibody (ANA) titers and antihistone titers. The clinical picture and laboratory abnormalities improved after discontinuation of the drug. Although systemic findings secondary to drug-induced lupus have been well described in the medical literature, this case represents the first detailed ophthalmologic documentation of scleritis as the presenting manifestation of procainamide-induced lupus.

Original languageEnglish (US)
Pages (from-to)68-71
Number of pages4
JournalOphthalmology
Volume96
Issue number1
StatePublished - 1989
Externally publishedYes

Fingerprint

Scleritis
Procainamide
Pharmaceutical Preparations
Antinuclear Antibodies
Myalgia
Arthralgia
Documentation
Signs and Symptoms
Weight Loss

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Scleritis as the presenting manifestation of procainamide-induced lupus. / Turgeon, P. W.; Slamovits, Thomas L.

In: Ophthalmology, Vol. 96, No. 1, 1989, p. 68-71.

Research output: Contribution to journalArticle

@article{ee363b705804490db8cc34330ed8fa8b,
title = "Scleritis as the presenting manifestation of procainamide-induced lupus",
abstract = "Scleritis developed in a patient using procainamide as part of drug-induced lupus syndrome. Systemic findings, which developed after the onset of ocular signs and symptoms, included arthralgias, myalgias, weight loss, and markedly elevated antinuclear antibody (ANA) titers and antihistone titers. The clinical picture and laboratory abnormalities improved after discontinuation of the drug. Although systemic findings secondary to drug-induced lupus have been well described in the medical literature, this case represents the first detailed ophthalmologic documentation of scleritis as the presenting manifestation of procainamide-induced lupus.",
author = "Turgeon, {P. W.} and Slamovits, {Thomas L.}",
year = "1989",
language = "English (US)",
volume = "96",
pages = "68--71",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Scleritis as the presenting manifestation of procainamide-induced lupus

AU - Turgeon, P. W.

AU - Slamovits, Thomas L.

PY - 1989

Y1 - 1989

N2 - Scleritis developed in a patient using procainamide as part of drug-induced lupus syndrome. Systemic findings, which developed after the onset of ocular signs and symptoms, included arthralgias, myalgias, weight loss, and markedly elevated antinuclear antibody (ANA) titers and antihistone titers. The clinical picture and laboratory abnormalities improved after discontinuation of the drug. Although systemic findings secondary to drug-induced lupus have been well described in the medical literature, this case represents the first detailed ophthalmologic documentation of scleritis as the presenting manifestation of procainamide-induced lupus.

AB - Scleritis developed in a patient using procainamide as part of drug-induced lupus syndrome. Systemic findings, which developed after the onset of ocular signs and symptoms, included arthralgias, myalgias, weight loss, and markedly elevated antinuclear antibody (ANA) titers and antihistone titers. The clinical picture and laboratory abnormalities improved after discontinuation of the drug. Although systemic findings secondary to drug-induced lupus have been well described in the medical literature, this case represents the first detailed ophthalmologic documentation of scleritis as the presenting manifestation of procainamide-induced lupus.

UR - http://www.scopus.com/inward/record.url?scp=0024562141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024562141&partnerID=8YFLogxK

M3 - Article

C2 - 2645552

AN - SCOPUS:0024562141

VL - 96

SP - 68

EP - 71

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 1

ER -